55I LLC’s Elevance Health ELV Stock Holding History

55I LLC’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.17M	Buy	2,563 +1,499	+141%	+$717K	0.03%	238
2022 Q2	$513K	Buy	+1,064	New	+$526K	0.01%	347

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

55I LLC's ELV Position: Q3 2022 in Review

55I LLC increased its Elevance Health (ELV) stake by 141% in Q3 2022, buying an estimated $717K and bringing the position to 2,563 shares worth $1.17M. The position accounts for 0.03% of the portfolio, ranked #238.

55I LLC first reported a position in ELV in Q2 2022 and has held it in 2 quarters since. 1,445 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

55I LLC held 2,563 shares of Elevance Health worth $1.17M as of Q3 2022.
55I LLC bought 1,499 Elevance Health shares in Q3 2022, an estimated $717K.
Elevance Health made up 0.03% of 55I LLC's portfolio in Q3 2022, its #238 holding.
55I LLC first reported a position in Elevance Health in Q2 2022 and has held it in 2 quarters since.
1,445 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.